Radial Artery Puncture Hemostasis Study
- Conditions
- Radial Artery Hemostasis
- Interventions
- Device: Radial artery hemostasis
- Registration Number
- NCT04857385
- Lead Sponsor
- Semmelweis University Heart and Vascular Center
- Brief Summary
RAPHE is an open label randomized clinical trial to assess physical, biological and chemical methods of radial artery puncture hemostasis following coronary catheterization.
A total of 600 subjects will be randomized in a 1:1:1 fashion to either the StatSeal, Axiostat or TR Band hemostasis devices.
Follow-up of the subject will take place 60 days after the index procedure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 600
- Coronary angiogram planned from a radial artery approach
- Use of 5, 6 or 7 French sheaths
- Radial artery diameter <1.8 mm as measured via ultrasound
- Established peripheral arterial disease
- Known autoimmune illness
- Hemodynamic instability
- Pregnant or nursing
- Condition following resuscitation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description StatSeal Radial artery hemostasis Potassium-ferrate based chemical hemostasis device. Terumo TR Band Radial artery hemostasis Physical standard of care radial hemostasis device. Axiostat Radial artery hemostasis Chitosan based biological hemostasis device.
- Primary Outcome Measures
Name Time Method Radial artery fistula formation 60 days (+/-10 days) post-procedure Frequency of radial artery arteriovenous fistula formation after hemostasis
Radial artery bleeding 60 days (+/-10 days) post-procedure Bleeding from the radial artery puncture, classified via the EASY method
Radial artery occlusion 60 days (+/-10 days) post-procedure Frequency of radial artery occlusion after hemostasis
Radial artery (pseudo)aneurysm formation 60 days (+/-10 days) post-procedure Frequency of radial artery (pseudo)aneurysm formation after hemostasis
- Secondary Outcome Measures
Name Time Method Overall compression time Up to 24 hours post-procedure Overall time (in minutes) of device use as a hemostatis tool
Initial compression time of hemostatsis device Up to 30 minutes post-procedure Initial time (in minutes) of the hemostasis device, needed to achieve primary patent hemostasis
Number of compression devices needed Up to 24 hours post-procedure Overall number of compression devices needed for hemostatis
Trial Locations
- Locations (3)
University of Szeged, Department of Invasive Cardiology
ðŸ‡ðŸ‡ºSzeged, Csongád-Csanád, Hungary
Department of Cardiology and Cardiac Surgery
ðŸ‡ðŸ‡ºDebrecen, Hajdú-Bihar, Hungary
Semmelweis University Heart and Vascular Center
ðŸ‡ðŸ‡ºBudapest, Hungary